Sale of a digital limited edition associated with the development of a Nobel Prize recognized cancer-fighting invention, a precursor to the patent, may provide businesses,
Tag: CRISPR
J&J says it is 5 months away from human trials on a Vaccine; Researchers Float License-Free COVID-19 Pledge
Johnson & Johnson, the pharmaceutical giant, said yesterday it is five months away from starting human trials on a COVID-19 vaccine that would be offered
Gene-editing break-through: can a collision of science, ethics and (patent) ownership be avoided?
The USPTO decided in February that the rightful intellectual property owner of CRISPR in eukaryotes, a time-saving tool that makes it cheaper and easier to
